4-phenylenediamine has been researched along with Cranial Nerve II Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, CT; Sretavan, D | 1 |
| Barakat, D; Bethea, JR; Brambilla, R; Dvoriantchikova, G; Ivanov, D; Shestopalov, VI | 1 |
2 other study(ies) available for 4-phenylenediamine and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.
Topics: Animals; Axons; Cell Survival; Coloring Agents; Disease Models, Animal; Ephrin-B2; Ephrin-B3; Glaucoma; Intraocular Pressure; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Degeneration; Ocular Hypertension; Optic Nerve Diseases; Organ Culture Techniques; Phenylenediamines; Recombinant Fusion Proteins; Retinal Ganglion Cells; Signal Transduction; Up-Regulation | 2012 |
Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Topics: Analysis of Variance; Animals; Astrocytes; Cell Count; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Glial Fibrillary Acidic Protein; Membrane Glycoproteins; Mice; Mice, Transgenic; Myelin-Oligodendrocyte Glycoprotein; NADPH Oxidase 2; NADPH Oxidases; Neutrophil Infiltration; NF-kappa B; Optic Nerve; Optic Nerve Diseases; Oxidative Stress; Peptide Fragments; Phenylenediamines; Phosphopyruvate Hydratase; Retinal Ganglion Cells | 2012 |